首页    期刊浏览 2024年11月30日 星期六
登录注册

文章基本信息

  • 标题:Using the bootstrap to establish statistical significance for relative validity comparisons among patient-reported outcome measures
  • 本地全文:下载
  • 作者:Nina Deng ; Jeroan J Allison ; Hua Julia Fang
  • 期刊名称:Health and Quality of Life Outcomes
  • 印刷版ISSN:1477-7525
  • 电子版ISSN:1477-7525
  • 出版年度:2013
  • 卷号:11
  • 期号:1
  • 页码:89
  • DOI:10.1186/1477-7525-11-89
  • 语种:English
  • 出版社:BioMed Central
  • 摘要:Relative validity (RV), a ratio of ANOVA F-statistics, is often used to compare the validity of patient-reported outcome (PRO) measures. We used the bootstrap to establish the statistical significance of the RV and to identify key factors affecting its significance. Based on responses from 453 chronic kidney disease (CKD) patients to 16 CKD-specific and generic PRO measures, RVs were computed to determine how well each measure discriminated across clinically-defined groups of patients compared to the most discriminating (reference) measure. Statistical significance of RV was quantified by the 95% bootstrap confidence interval. Simulations examined the effects of sample size, denominator F-statistic, correlation between comparator and reference measures, and number of bootstrap replicates. The statistical significance of the RV increased as the magnitude of denominator F-statistic increased or as the correlation between comparator and reference measures increased. A denominator F-statistic of 57 conveyed sufficient power (80%) to detect an RV of 0.6 for two measures correlated at r = 0.7. Larger denominator F-statistics or higher correlations provided greater power. Larger sample size with a fixed denominator F-statistic or more bootstrap replicates (beyond 500) had minimal impact. The bootstrap is valuable for establishing the statistical significance of RV estimates. A reasonably large denominator F-statistic (F > 57) is required for adequate power when using the RV to compare the validity of measures with small or moderate correlations (r 0.9).
  • 关键词:Bootstrap ; Relative validity ; Analysis of variance (ANOVA) ; Confidence interval ; Patient-reported outcome (PRO) measure ; Chronic kidney disease (CKD)
国家哲学社会科学文献中心版权所有